Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_assertion type Assertion NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_head.
- NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_assertion description "[In addition, C2GnT, which was specifically detected in cancer tissues of 63% of patients, was closely correlated with the vessel invasion, as well as depth of tumor invasion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_provenance.
- NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_assertion evidence source_evidence_literature NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_provenance.
- NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_assertion SIO_000772 9393734 NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_provenance.
- NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_assertion wasDerivedFrom befree-20140225 NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_provenance.
- NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_assertion wasGeneratedBy ECO_0000203 NP650957.RAkHNkgCN5aR6FzFkrD_W__ZCfseF0ouCcys-T0LLO2U8130_provenance.